The summary below is from the full report titled “Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility Analysis.” It is in the 7 March 2006 issue of Annals of Internal Medicine (volume 144, pages 326-336). The authors are M. Pignone, S. Earnshaw, J.A. Tice, and M.J. Pletcher.
The Cost-Effectiveness of Aspirin, Statins, or Both Drugs in the Primary Prevention of Heart Disease. Ann Intern Med. 2006;144:I–29. doi: https://doi.org/10.7326/0003-4819-144-5-200603070-00003
Download citation file:
Published: Ann Intern Med. 2006;144(5):I-29.
Cardiology, Coronary Risk Factors, Dyslipidemia, Healthcare Delivery and Policy, Prevention/Screening.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use